{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:28:13Z","timestamp":1769578093186,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T00:00:00Z","timestamp":1332547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00520-012-1427-6","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T11:03:15Z","timestamp":1332500595000},"page":"2949-2958","source":"Crossref","is-referenced-by-count":17,"title":["Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer"],"prefix":"10.1007","volume":"20","author":[{"given":"E.","family":"Zilliacus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Meiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Lobb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,24]]},"reference":[{"key":"1427_CR1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(03)12856-5","volume":"361","author":"F Lalloo","year":"2003","unstructured":"Lalloo F et al (2003) Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet 361:1101","journal-title":"Lancet"},{"issue":"9","key":"1427_CR2","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2004.04.179","volume":"22","author":"D Choi","year":"2004","unstructured":"Choi D et al (2004) Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22(9):1638\u20131645","journal-title":"J Clin Oncol"},{"key":"1427_CR3","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jnci\/93.16.1215","volume":"93","author":"N Loman","year":"2001","unstructured":"Loman N et al (2001) Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset cancer. J Nat Cancer Inst 93:1215\u20131223","journal-title":"J Nat Cancer Inst"},{"issue":"5","key":"1427_CR4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/humu.9188","volume":"22","author":"J Martinez-Ferrandis","year":"2003","unstructured":"Martinez-Ferrandis J et al (2003) Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations. Hum Mutat 22(5):417\u2013418","journal-title":"Hum Mutat"},{"issue":"1","key":"1427_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10689-007-9147-7","volume":"7","author":"W Rubenstein","year":"2008","unstructured":"Rubenstein W (2008) Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics. Fam Cancer 7(1):83\u201389","journal-title":"Fam Cancer"},{"key":"1427_CR6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10689-007-9167-3","volume":"7","author":"E Silva","year":"2008","unstructured":"Silva E (2008) Genetic counselling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist. Familial Cancer 7:91\u201395","journal-title":"Familial Cancer"},{"key":"1427_CR7","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1038\/sj.onc.1209881","volume":"25","author":"S Domcheck","year":"2006","unstructured":"Domcheck S, Weber B (2006) Clinical management of BRCA1 and BRCA2 mutation carriers. Oncogene 25:5825\u20135831","journal-title":"Oncogene"},{"key":"1427_CR8","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1200\/JCO.2005.10.035","volume":"23","author":"S Narod","year":"2005","unstructured":"Narod S, Orrit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23:1656\u20131663","journal-title":"J Clin Oncol"},{"key":"1427_CR9","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2000.18.19.3360","volume":"18","author":"L Pierce","year":"2000","unstructured":"Pierce L, Strawderman M, Narod S (2000) Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1\/2 mutations. J Clin Oncol 18:3360\u20133369","journal-title":"J Clin Oncol"},{"issue":"2","key":"1427_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"L Hartmann","year":"1999","unstructured":"Hartmann L et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77\u201384","journal-title":"N Engl J Med"},{"issue":"31","key":"1427_CR11","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1200\/JCO.2005.08.903","volume":"23","author":"M Schwartz","year":"2005","unstructured":"Schwartz M (2005) Contralateral prophylactic mastectomy: efficacy, satisfaction, and regret. J Clin Oncol 23(31):7777\u20137779","journal-title":"J Clin Oncol"},{"issue":"9","key":"1427_CR12","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.2000.18.9.1980","volume":"18","author":"A Eisen","year":"2000","unstructured":"Eisen A et al (2000) Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 18(9):1980\u20131995","journal-title":"J Clin Oncol"},{"issue":"21","key":"1427_CR13","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satogopan JM, Robson ME (2002) Risk-reducing salpingo-oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1609\u20131615","journal-title":"N Engl J Med"},{"issue":"10","key":"1427_CR14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2004.04.086","volume":"22","author":"C Schwartz","year":"2004","unstructured":"Schwartz C et al (2004) Impact of BRCA1\/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 22(10):1823\u20131829","journal-title":"J Clin Oncol"},{"issue":"6","key":"1427_CR15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/bcr2194","volume":"10","author":"B Meiser","year":"2008","unstructured":"Meiser B et al (2008) Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Res 10(6):216","journal-title":"Breast Cancer Res"},{"issue":"13","key":"1427_CR16","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1200\/JCO.2005.05.157","volume":"23","author":"M Palomares","year":"2005","unstructured":"Palomares M, Paz B, Weitzel J (2005) Genetic cancer risk assessment in the newly diagnosed breast cancer patient is useful and possible in practice. J Clin Oncol 23(13):3165\u20133166","journal-title":"J Clin Oncol"},{"key":"1427_CR17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archsurg.138.12.1323","volume":"138","author":"J Weitzel","year":"2003","unstructured":"Weitzel J et al (2003) Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg 138:1323\u20131328","journal-title":"Arch Surg"},{"key":"1427_CR18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1075-122X.2004.21543.x","volume":"10","author":"A Stolier","year":"2004","unstructured":"Stolier A et al (2004) Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA1 or BRCA2 mutation [see comment]. Breast J 10:475\u2013480","journal-title":"Breast J"},{"issue":"4","key":"1427_CR19","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/1055-9965.EPI-03-0545","volume":"14","author":"M Schwartz","year":"2005","unstructured":"Schwartz M et al (2005) Utilization of BRCA1\/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev 14(4):1003\u20131007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"16","key":"1427_CR20","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.ejca.2006.05.032","volume":"42","author":"KJ Schlich-Bakker","year":"2006","unstructured":"Schlich-Bakker KJ et al (2006) Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer. Eur J Cancer 42(16):2722\u20132728","journal-title":"Eur J Cancer"},{"issue":"11","key":"1427_CR21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/GIM.0b013e318159a318","volume":"9","author":"KJ Schlich-Bakker","year":"2007","unstructured":"Schlich-Bakker KJ et al (2007) Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer. Genet Med 9(11):766\u2013777","journal-title":"Genet Med"},{"key":"1427_CR22","volume-title":"Clinical practice guidelines: familial aspects of cancer: a guide to clinical practice","author":"NHMRC","year":"1999","unstructured":"NHMRC (1999) Clinical practice guidelines: familial aspects of cancer: a guide to clinical practice. NHMRC, Canberra"},{"key":"1427_CR23","unstructured":"Australian Commonwealth Department of Health and Ageing (2008) Private Health Insurance Administration Council. October 10, 2008. Available from http:\/\/www.phiac.gov.au\/"},{"key":"1427_CR24","doi-asserted-by":"crossref","unstructured":"Meiser B et al (2011) Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing. Oncol Nurs Forum 39(2):E101\u2013E111","DOI":"10.1188\/12.ONF.E101-E111"},{"key":"1427_CR25","volume-title":"Qualitative data analysis: a sourcebook for new methods","author":"M Miles","year":"1984","unstructured":"Miles M, Huberman M (1984) Qualitative data analysis: a sourcebook for new methods. Sage, Beverly Hills"},{"key":"1427_CR26","volume-title":"Handbook of qualitative research","year":"1994","unstructured":"Denzin JM, Lincoln YS (eds) (1994) Handbook of qualitative research. Sage, London"},{"issue":"3","key":"1427_CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/10906570050501489","volume":"4","author":"M Wood","year":"2000","unstructured":"Wood M et al (2000) Impact of BRCA1 testing on women with cancer: a pilot study. Genet Test 4(3):265\u2013272","journal-title":"Genet Test"},{"key":"1427_CR28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ajmg.a.20374","volume":"124","author":"M Roosmalen van","year":"2004","unstructured":"van Roosmalen M et al (2004) Impact of BRCA1\/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. Am J Med Genet 124:346\u2013355","journal-title":"Am J Med Genet"},{"key":"1427_CR29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2354.2005.00574.x","volume":"14","author":"A Ardern-Jones","year":"2005","unstructured":"Ardern-Jones A, Kenen R, Eeles R (2005) Too much too soon? Patients\u2019 and health professionals\u2019 views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. Eur J Cancer Care 14:272\u2013281","journal-title":"Eur J Cancer Care"},{"issue":"1","key":"1427_CR30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1524-4741.2010.01027.x","volume":"17","author":"ST Vadaparampil","year":"2011","unstructured":"Vadaparampil ST et al (2011) Satisfaction with physician recommendation for and information about genetic counselling among breast cancer patients. The Breast J 17(1):79\u201382","journal-title":"The Breast J"},{"issue":"4","key":"1427_CR31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1399-0004.2009.01307.x","volume":"77","author":"E Lobb","year":"2010","unstructured":"Lobb E et al (2010) Treatment focussed DNA testing in newly diagnosed cancer patients: some implications for clinical practice. Clin Gen 77(4):350\u2013354","journal-title":"Clin Gen"},{"issue":"3","key":"1427_CR32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-007-9680-y","volume":"109","author":"KJ Schlich-Bakker","year":"2008","unstructured":"Schlich-Bakker KJ et al (2008) BRCA 1\/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy. Breast Cancer Res Treat 109(3):507\u2013514","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1427_CR33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1200\/JCO.2006.07.3890","volume":"25","author":"KP Tercyak","year":"2007","unstructured":"Tercyak KP et al (2007) Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1\/2. J Clin Oncol 25(3):285\u2013291","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1427-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-012-1427-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1427-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:04:15Z","timestamp":1559081055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-012-1427-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,24]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1427"],"URL":"https:\/\/doi.org\/10.1007\/s00520-012-1427-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,24]]}}}